//Celgene acquires Delinia

Celgene acquires Delinia

Three weeks after their graduation party, Delinia announced they had been acquired by Celgene for $300M upfront and up to $475M in milestones. Delinia’s co-founder and CSO, Jeff Greve, began with a single bench at QB3@953 in 2014. Less than two years later, he has delivered an exciting autoimmune candidate to Celgene – now that’s awesome!


2018-09-25T11:28:03+00:00February 3rd, 2017|Alumni News|